Human Subject Protection and Financial Conflicts of Interest Conference
August, 2000

Purpose | Agenda | Background Materials | Comments (updated 12/11/2000)

Notice: The comment period expired on September 30, 2000.

Questions for Comment


The issue of financial conflicts of interest in research is one of the five main issues identified by the Secretary of Health and Human Services in her announcement of steps being taken to strengthen human subject protection during clinical trials. (Ref. Press Release and Backgrounder, 5/23/00). In that announcement, the Secretary stated that HHS would hold public discussions this summer to find new ways to manage conflicts of interest so that research subjects are appropriately informed, and to further ensure that research results are analyzed and presented objectively. In addition, these public discussions also will focus on clarifying and enhancing the informed consent process.

A conference was held August 15-16, 2000 at the National Institutes for Health in Bethesda, Maryland in order to

Conference Agenda and Speakers

Transcript of August 15 session (Presentations also linked from agenda.)

Transcript of August 16 session (Presentations also linked from agenda.)

Background Materials

Announcement in the Federal Register

Comments were addressed to our email box at or otherwise addressed to

Stuart Nightingale, M.D.
Office of the Assistant Secretary for Planning and Evaluation
Hubert H. Humphrey Bldg., Room 447D
200 Independence Ave., S.W.
Washington, D.C. 20201

Top of Page | Purpose | Agenda | Background Materials | Comments Received

Conference Sponsor's Web Sites
U.S. Department of Health and Human Services (HHS) - Office of the Secretary
Assistant Secretary for Planning and Evaluation (ASPE)
National Institutes of Health (NIH)
Centers for Disease Control and Prevention (CDC)
Food and Drug Administration (FDA)

Back to OHRP Home Page

Questions/suggestions about this web page?  Webmaster
Updated July 16, 2001